152 related articles for article (PubMed ID: 16395701)
1. Dietary administration with prenyloxycoumarins, auraptene and collinin, inhibits colitis-related colon carcinogenesis in mice.
Kohno H; Suzuki R; Curini M; Epifano F; Maltese F; Gonzales SP; Tanaka T
Int J Cancer; 2006 Jun; 118(12):2936-42. PubMed ID: 16395701
[TBL] [Abstract][Full Text] [Related]
2. Suppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligands.
Kohno H; Suzuki R; Sugie S; Tanaka T
BMC Cancer; 2005 May; 5():46. PubMed ID: 15892897
[TBL] [Abstract][Full Text] [Related]
3. Citrus compounds inhibit inflammation- and obesity-related colon carcinogenesis in mice.
Tanaka T; Yasui Y; Ishigamori-Suzuki R; Oyama T
Nutr Cancer; 2008; 60 Suppl 1():70-80. PubMed ID: 19003583
[TBL] [Abstract][Full Text] [Related]
4. Ursodeoxycholic acid versus sulfasalazine in colitis-related colon carcinogenesis in mice.
Kohno H; Suzuki R; Yasui Y; Miyamoto S; Wakabayashi K; Tanaka T
Clin Cancer Res; 2007 Apr; 13(8):2519-25. PubMed ID: 17438113
[TBL] [Abstract][Full Text] [Related]
5. Beta-Catenin mutations in a mouse model of inflammation-related colon carcinogenesis induced by 1,2-dimethylhydrazine and dextran sodium sulfate.
Kohno H; Suzuki R; Sugie S; Tanaka T
Cancer Sci; 2005 Feb; 96(2):69-76. PubMed ID: 15723650
[TBL] [Abstract][Full Text] [Related]
6. Colorectal cancer chemoprevention by 2 beta-cyclodextrin inclusion compounds of auraptene and 4'-geranyloxyferulic acid.
Tanaka T; de Azevedo MB; Durán N; Alderete JB; Epifano F; Genovese S; Tanaka M; Tanaka T; Curini M
Int J Cancer; 2010 Feb; 126(4):830-40. PubMed ID: 19688830
[TBL] [Abstract][Full Text] [Related]
7. A specific inducible nitric oxide synthase inhibitor, ONO-1714 attenuates inflammation-related large bowel carcinogenesis in male Apc(Min/+) mice.
Kohno H; Takahashi M; Yasui Y; Suzuki R; Miyamoto S; Kamanaka Y; Naka M; Maruyama T; Wakabayashi K; Tanaka T
Int J Cancer; 2007 Aug; 121(3):506-13. PubMed ID: 17417780
[TBL] [Abstract][Full Text] [Related]
8. A novel prodrug of 4'-geranyloxy-ferulic acid suppresses colitis-related colon carcinogenesis in mice.
Miyamoto S; Epifano F; Curini M; Genovese S; Kim M; Ishigamori-Suzuki R; Yasui Y; Sugie S; Tanaka T
Nutr Cancer; 2008; 60(5):675-84. PubMed ID: 18791932
[TBL] [Abstract][Full Text] [Related]
9. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
[TBL] [Abstract][Full Text] [Related]
10. Chemopreventive effects of the standardized extract (DA-9601) of Artemisia asiatica on azoxymethane-initiated and dextran sulfate sodium-promoted mouse colon carcinogenesis.
Kim HS; Kundu JK; Lee JS; Oh TY; Na HK; Surh YJ
Nutr Cancer; 2008; 60 Suppl 1():90-7. PubMed ID: 19003585
[TBL] [Abstract][Full Text] [Related]
11. Citrus auraptene exerts dose-dependent chemopreventive activity in rat large bowel tumorigenesis: the inhibition correlates with suppression of cell proliferation and lipid peroxidation and with induction of phase II drug-metabolizing enzymes.
Tanaka T; Kawabata K; Kakumoto M; Hara A; Murakami A; Kuki W; Takahashi Y; Yonei H; Maeda M; Ota T; Odashima S; Yamane T; Koshimizu K; Ohigashi H
Cancer Res; 1998 Jun; 58(12):2550-6. PubMed ID: 9635577
[TBL] [Abstract][Full Text] [Related]
12. Organomagnesium suppresses inflammation-associated colon carcinogenesis in male Crj: CD-1 mice.
Kuno T; Hatano Y; Tomita H; Hara A; Hirose Y; Hirata A; Mori H; Terasaki M; Masuda S; Tanaka T
Carcinogenesis; 2013 Feb; 34(2):361-9. PubMed ID: 23125223
[TBL] [Abstract][Full Text] [Related]
13. Chemoprevention of colon cancer by a glutathione conjugate of 1,4-phenylenebis(methylene)selenocyanate, a novel organoselenium compound with low toxicity.
Rao CV; Wang CQ; Simi B; Rodriguez JG; Cooma I; El-Bayoumy K; Reddy BS
Cancer Res; 2001 May; 61(9):3647-52. PubMed ID: 11325834
[TBL] [Abstract][Full Text] [Related]
14. A lipophilic statin, pitavastatin, suppresses inflammation-associated mouse colon carcinogenesis.
Yasui Y; Suzuki R; Miyamoto S; Tsukamoto T; Sugie S; Kohno H; Tanaka T
Int J Cancer; 2007 Nov; 121(10):2331-9. PubMed ID: 17657716
[TBL] [Abstract][Full Text] [Related]
15. Prevention of colonic aberrant crypt foci by dietary feeding of garcinol in male F344 rats.
Tanaka T; Kohno H; Shimada R; Kagami S; Yamaguchi F; Kataoka S; Ariga T; Murakami A; Koshimizu K; Ohigashi H
Carcinogenesis; 2000 Jun; 21(6):1183-9. PubMed ID: 10837008
[TBL] [Abstract][Full Text] [Related]
16. Nobiletin and its colonic metabolites suppress colitis-associated colon carcinogenesis by down-regulating iNOS, inducing antioxidative enzymes and arresting cell cycle progression.
Wu X; Song M; Gao Z; Sun Y; Wang M; Li F; Zheng J; Xiao H
J Nutr Biochem; 2017 Apr; 42():17-25. PubMed ID: 28107678
[TBL] [Abstract][Full Text] [Related]
17. Dietary astaxanthin inhibits colitis and colitis-associated colon carcinogenesis in mice via modulation of the inflammatory cytokines.
Yasui Y; Hosokawa M; Mikami N; Miyashita K; Tanaka T
Chem Biol Interact; 2011 Aug; 193(1):79-87. PubMed ID: 21621527
[TBL] [Abstract][Full Text] [Related]
18. Suppressive effects of Moringa oleifera Lam pod against mouse colon carcinogenesis induced by azoxymethane and dextran sodium sulfate.
Budda S; Butryee C; Tuntipopipat S; Rungsipipat A; Wangnaithum S; Lee JS; Kupradinun P
Asian Pac J Cancer Prev; 2011; 12(12):3221-8. PubMed ID: 22471457
[TBL] [Abstract][Full Text] [Related]
19. Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic process.
Reddy BS; Kawamori T; Lubet RA; Steele VE; Kelloff GJ; Rao CV
Cancer Res; 1999 Jul; 59(14):3387-91. PubMed ID: 10416599
[TBL] [Abstract][Full Text] [Related]
20. Dietary supplementation of the citrus antioxidant auraptene inhibits N,N-diethylnitrosamine-induced rat hepatocarcinogenesis.
Sakata K; Hara A; Hirose Y; Yamada Y; Kuno T; Katayama M; Yoshida K; Zheng Q; Murakami A; Ohigashi H; Ikemoto K; Koshimizu K; Tanaka T; Mori H
Oncology; 2004; 66(3):244-52. PubMed ID: 15218316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
